{
  "main_header": {
    "sid": 505931,
    "name": "Shukra Pharma.",
    "stock_name": "Shukra Pharma.",
    "full_name": "Shukra Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/shukra-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "18.62",
    "chg": -0.38,
    "chgp": "-2.0%",
    "dir": -1,
    "prev_price": "19.00",
    "mcapval": "815.33 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524632,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE551C01044",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:27 AM",
    "bse_nse_vol": "7.11 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shukra-pharma-505931-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-faces-selling-pressure-with-2-00-decline-amid-eight-day-loss-streak-1696332",
        "imagepath": "",
        "date": "2025-04-03 11:25:12",
        "description": "Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past eight days, resulting in a total loss of 14.43% during this period. Today, Shukra Pharmaceuticals reported a performance drop of 2.00%, notably underperforming the Sensex, which fell by only 0.34%.\n\nIn the past week, the stock has declined by 7.51%, while the Sensex has decreased by 1.61%. Over the last month, Shukra Pharmaceuticals has seen a substantial drop of 16.60%, contrasting sharply with the Sensex's gain of 4.47%. Despite a remarkable performance over the longer term, including a 167.79% increase over the past year, the recent trend indicates a shift in market sentiment.\n\nThe stock's current price performance is also noteworthy, as it is higher than the 100-day and 200-day moving averages but lower than the 5-day, 20-..."
      },
      {
        "title": "Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-faces-selling-pressure-with-1-96-decline-amidst-7-day-loss-of-12-68-1673833",
        "imagepath": "",
        "date": "2025-04-02 10:35:16",
        "description": "Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past seven days, resulting in a total loss of 12.68%. Today's performance reflects a decrease of 1.96%, contrasting sharply with the Sensex, which has gained 0.52%.\n\nOver the past week, Shukra Pharmaceuticals has declined by 7.49%, while the Sensex has only dipped by 1.12%. The stock's performance over the last month shows a notable drop of 10.64%, compared to the Sensex's increase of 4.40%. Despite a strong performance in the longer term, with a remarkable 167.81% increase over the past year, the recent trend indicates a shift in market sentiment.\n\nThe stock is currently underperforming its sector by 1.8%. While it remains above its 100-day and 200-day moving averages, it is below its 5-day, 20-day, and 50-day moving averages, sug..."
      },
      {
        "title": "Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-faces-significant-selling-pressure-with-1-97-decline-amid-ongoing-losses-1661737",
        "imagepath": "",
        "date": "2025-04-01 12:25:10",
        "description": "Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past six days, resulting in a total loss of 10.94% during this period. Today, Shukra Pharmaceuticals reported a performance drop of 1.97%, underperforming the Sensex, which fell by 1.59%.\n\nIn the past week, the stock has declined by 7.47%, while the Sensex decreased by 2.35%. Over the last month, Shukra Pharmaceuticals has seen a notable decline of 8.85%, contrasting sharply with the Sensex's gain of 4.08%. Despite a strong performance in the longer term, including a remarkable 167.71% increase over the past year, the recent trend indicates a shift in market sentiment.\n\nThe stock's current price is above its 100-day and 200-day moving averages but below its 5-day, 20-day, and 50-day moving averages, suggesting a potential shift in ..."
      },
      {
        "title": "Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-faces-selling-pressure-with-1-80-decline-amidst-9-15-weekly-loss-1641889",
        "imagepath": "",
        "date": "2025-03-28 11:25:11",
        "description": "Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past five days, resulting in a total loss of 9.15%. In today's trading session, Shukra Pharmaceuticals fell by 1.80%, underperforming the Sensex, which only dipped by 0.03%.\n\nOver the past week, the stock's performance has been notably poor, with a 9.15% decline compared to the Sensex's gain of 0.88%. In the last month, Shukra Pharmaceuticals has dropped 7.02%, while the Sensex has risen by 5.99%. Despite a strong performance in the longer term, including a remarkable 6906.57% increase over three years, the recent trend indicates a shift in market sentiment.\n\nThe stock's current price is below its 5-day, 20-day, and 50-day moving averages, although it remains above the 100-day and 200-day moving averages. This divergence may sugges..."
      },
      {
        "title": "Shukra Pharmaceuticals Faces Shift in Market Sentiment Amid Declining Sales and Strong Debt Management",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-stock-downgraded-to-sell-amid-declining-profits-and-sales-1636987",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/ShukraPharmaceu_mojoScore_830672.png",
        "date": "2025-03-28 08:03:36",
        "description": "Shukra Pharmaceuticals has recently experienced an evaluation adjustment reflecting a shift in its technical trends. Despite facing challenges with declining net sales, the company maintains a strong debt management profile. Its long-term operating profit growth suggests resilience, while the absence of domestic mutual fund investment indicates cautious market sentiment."
      },
      {
        "title": "Shukra Pharmaceuticals Shows Mixed Technical Trends Amidst Strong Long-Term Growth",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-price-decline-1636781",
        "imagepath": "",
        "date": "2025-03-28 08:01:34",
        "description": "Shukra Pharmaceuticals, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 22.25, slightly down from the previous close of 22.70. Over the past year, Shukra Pharmaceuticals has demonstrated remarkable performance, with a return of 167.11%, significantly outpacing the Sensex's 6.32% return during the same period.\n\nThe technical summary indicates a mixed outlook, with the MACD showing bullish signals on both weekly and monthly charts. However, the KST presents a contrasting view, being bullish weekly but mildly bearish monthly. The Bollinger Bands and moving averages suggest a mildly bullish trend, while the Dow Theory reflects a mildly bearish stance on a weekly basis.\n\nIn terms of stock performance, Shukra Pharmaceuticals has shown impressive long-term growth, with a staggering 7034..."
      },
      {
        "title": "Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Recent Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-faces-significant-selling-pressure-with-7-48-decline-over-four-days-1624372",
        "imagepath": "",
        "date": "2025-03-27 11:20:15",
        "description": "Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past four days, resulting in a total loss of 7.48%. Today, the stock fell by 1.98%, underperforming the Sensex, which gained 0.49%. \n\nIn the past week, Shukra Pharmaceuticals has seen a decline of 5.72%, while the Sensex rose by 1.73%. Over the last month, the stock has decreased by 0.67%, compared to the Sensex's increase of 4.10%. Despite a strong performance over the longer term, including a remarkable 167.11% gain over the past year, the recent trend indicates a shift in market sentiment.\n\nThe stock's current price is higher than its 100-day and 200-day moving averages but lower than its 5-day, 20-day, and 50-day moving averages, suggesting a potential short-term weakness. Factors contributing to the selling pressure may includ..."
      },
      {
        "title": "Shukra Pharmaceuticals Faces Increased Selling Pressure Amid Recent Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-faces-selling-pressure-with-1-94-decline-amidst-ongoing-losses-1602826",
        "imagepath": "",
        "date": "2025-03-26 11:25:17",
        "description": "Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past three days, resulting in a total loss of 5.61% during this period. Today, Shukra Pharmaceuticals reported a performance drop of 1.94%, notably underperforming against the Sensex, which fell by only 0.21%.\n\nIn the broader context, Shukra Pharmaceuticals has shown mixed performance relative to the Sensex over various time frames. While it has posted impressive gains over the past year, with a 167.10% increase compared to the Sensex's 7.43%, the recent week has seen a decline of 5.73% against the Sensex's rise of 3.19%. \n\nThe stock's price summary indicates that it is currently underperforming its sector by 1.41%. Despite being above the 50-day, 100-day, and 200-day moving averages, it is below the 5-day and 20-day moving average..."
      },
      {
        "title": "Shukra Pharmaceuticals Faces Increased Selling Pressure Amid Recent Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-faces-selling-pressure-with-1-91-decline-amidst-consecutive-losses-1580255",
        "imagepath": "",
        "date": "2025-03-25 11:20:15",
        "description": "Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past two days, with a total decline of 3.74%. Today, the stock fell by 1.91%, underperforming the Sensex, which gained 0.18%. \n\nIn the past week, Shukra Pharmaceuticals has seen a notable decline of 5.78%, while the Sensex rose by 3.75%. Despite a strong performance over the longer term, including a remarkable 166.97% increase over the past year, the recent trend indicates a shift in market sentiment. \n\nThe stock's performance relative to the Sensex highlights a stark contrast, particularly in the short term, where it has underperformed the index. The price summary indicates that while Shukra Pharmaceuticals remains above its 50-day, 100-day, and 200-day moving averages, it is currently below its 5-day and 20-day moving averages. This..."
      }
    ],
    "total": 116,
    "sid": "505931",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/shukra-pharmaceuticals-505931"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "05-Apr-2025",
      "details": "Compliance certificate under Reg. 74(5) of SEBI (DP) reg.2018 for the quarter ended 31.03.2025.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Change In Secretarial Auditor Of The Company",
      "datetime": "29-Mar-2025",
      "details": "Intimation of change in Secretarial Auditor of the company",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of Independent Directors Meeting Dated March 26 2025.",
      "datetime": "26-Mar-2025",
      "details": "Outcome of the meeting of Independent directors held on today to consider the agendas as attached.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has declared <strong>10%</strong> dividend, ex-date: 23 Sep 24",
          "dt": "2024-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 21 Mar 25",
          "dt": "2025-03-21",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Apr 24",
          "dt": "2024-04-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>6:1</strong> rights issue, ex-date: 02 Feb 23",
          "dt": "2023-02-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Significant Price Declines

2025-04-03 11:25:12

Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past eight days, resulting in a total loss of 14.43% during this period. Today, Shukra Pharmaceuticals reported a performance drop of 2.00%, notably underperforming the Sensex, which fell by only 0.34%. In the past week, the stock has declined by 7.51%, while the Sensex has decreased by 1.61%. Over the last month, Shukra Pharmaceuticals has seen a substantial drop of 16.60%, contrasting sharply with the Sensex's gain of 4.47%. Despite a remarkable performance over the longer term, including a 167.79% increase over the past year, the recent trend indicates a shift in market sentiment. The stock's current price performance is also noteworthy, as it is higher than the 100-day and 200-day moving averages but lower than the 5-day, 20-...

Read More

Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Significant Price Declines

2025-04-02 10:35:16

Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past seven days, resulting in a total loss of 12.68%. Today's performance reflects a decrease of 1.96%, contrasting sharply with the Sensex, which has gained 0.52%. Over the past week, Shukra Pharmaceuticals has declined by 7.49%, while the Sensex has only dipped by 1.12%. The stock's performance over the last month shows a notable drop of 10.64%, compared to the Sensex's increase of 4.40%. Despite a strong performance in the longer term, with a remarkable 167.81% increase over the past year, the recent trend indicates a shift in market sentiment. The stock is currently underperforming its sector by 1.8%. While it remains above its 100-day and 200-day moving averages, it is below its 5-day, 20-day, and 50-day moving averages, sug...

Read More

Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Significant Price Declines

2025-04-01 12:25:10

Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past six days, resulting in a total loss of 10.94% during this period. Today, Shukra Pharmaceuticals reported a performance drop of 1.97%, underperforming the Sensex, which fell by 1.59%. In the past week, the stock has declined by 7.47%, while the Sensex decreased by 2.35%. Over the last month, Shukra Pharmaceuticals has seen a notable decline of 8.85%, contrasting sharply with the Sensex's gain of 4.08%. Despite a strong performance in the longer term, including a remarkable 167.71% increase over the past year, the recent trend indicates a shift in market sentiment. The stock's current price is above its 100-day and 200-day moving averages but below its 5-day, 20-day, and 50-day moving averages, suggesting a potential shift in ...

Read More

Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Significant Price Declines

2025-03-28 11:25:11

Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past five days, resulting in a total loss of 9.15%. In today's trading session, Shukra Pharmaceuticals fell by 1.80%, underperforming the Sensex, which only dipped by 0.03%. Over the past week, the stock's performance has been notably poor, with a 9.15% decline compared to the Sensex's gain of 0.88%. In the last month, Shukra Pharmaceuticals has dropped 7.02%, while the Sensex has risen by 5.99%. Despite a strong performance in the longer term, including a remarkable 6906.57% increase over three years, the recent trend indicates a shift in market sentiment. The stock's current price is below its 5-day, 20-day, and 50-day moving averages, although it remains above the 100-day and 200-day moving averages. This divergence may sugges...

Read More

Shukra Pharmaceuticals Faces Shift in Market Sentiment Amid Declining Sales and Strong Debt Management

2025-03-28 08:03:36

Shukra Pharmaceuticals has recently experienced an evaluation adjustment reflecting a shift in its technical trends. Despite facing challenges with declining net sales, the company maintains a strong debt management profile. Its long-term operating profit growth suggests resilience, while the absence of domestic mutual fund investment indicates cautious market sentiment.

Read More

Shukra Pharmaceuticals Shows Mixed Technical Trends Amidst Strong Long-Term Growth

2025-03-28 08:01:34

Shukra Pharmaceuticals, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 22.25, slightly down from the previous close of 22.70. Over the past year, Shukra Pharmaceuticals has demonstrated remarkable performance, with a return of 167.11%, significantly outpacing the Sensex's 6.32% return during the same period. The technical summary indicates a mixed outlook, with the MACD showing bullish signals on both weekly and monthly charts. However, the KST presents a contrasting view, being bullish weekly but mildly bearish monthly. The Bollinger Bands and moving averages suggest a mildly bullish trend, while the Dow Theory reflects a mildly bearish stance on a weekly basis. In terms of stock performance, Shukra Pharmaceuticals has shown impressive long-term growth, with a staggering 7034...

Read More

Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Recent Price Declines

2025-03-27 11:20:15

Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past four days, resulting in a total loss of 7.48%. Today, the stock fell by 1.98%, underperforming the Sensex, which gained 0.49%. In the past week, Shukra Pharmaceuticals has seen a decline of 5.72%, while the Sensex rose by 1.73%. Over the last month, the stock has decreased by 0.67%, compared to the Sensex's increase of 4.10%. Despite a strong performance over the longer term, including a remarkable 167.11% gain over the past year, the recent trend indicates a shift in market sentiment. The stock's current price is higher than its 100-day and 200-day moving averages but lower than its 5-day, 20-day, and 50-day moving averages, suggesting a potential short-term weakness. Factors contributing to the selling pressure may includ...

Read More

Shukra Pharmaceuticals Faces Increased Selling Pressure Amid Recent Price Declines

2025-03-26 11:25:17

Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past three days, resulting in a total loss of 5.61% during this period. Today, Shukra Pharmaceuticals reported a performance drop of 1.94%, notably underperforming against the Sensex, which fell by only 0.21%. In the broader context, Shukra Pharmaceuticals has shown mixed performance relative to the Sensex over various time frames. While it has posted impressive gains over the past year, with a 167.10% increase compared to the Sensex's 7.43%, the recent week has seen a decline of 5.73% against the Sensex's rise of 3.19%. The stock's price summary indicates that it is currently underperforming its sector by 1.41%. Despite being above the 50-day, 100-day, and 200-day moving averages, it is below the 5-day and 20-day moving average...

Read More

Shukra Pharmaceuticals Faces Increased Selling Pressure Amid Recent Price Declines

2025-03-25 11:20:15

Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past two days, with a total decline of 3.74%. Today, the stock fell by 1.91%, underperforming the Sensex, which gained 0.18%. In the past week, Shukra Pharmaceuticals has seen a notable decline of 5.78%, while the Sensex rose by 3.75%. Despite a strong performance over the longer term, including a remarkable 166.97% increase over the past year, the recent trend indicates a shift in market sentiment. The stock's performance relative to the Sensex highlights a stark contrast, particularly in the short term, where it has underperformed the index. The price summary indicates that while Shukra Pharmaceuticals remains above its 50-day, 100-day, and 200-day moving averages, it is currently below its 5-day and 20-day moving averages. This...

Read More

View All News